Published guidance, NICE advice and quality standards | Guidance

Showing 421 to 430 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Letermovir for preventing cytomegalovirus disease after a stem cell transplant	TA591	31 July 2019	31 July 2019
Nusinersen for treating spinal muscular atrophy	TA588	24 July 2019	24 July 2019
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activity	TA589	24 July 2019	24 July 2019
Bisphosphonates for treating osteoporosis	TA464	9 August 2017	8 July 2019
Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality	TA322	24 September 2014	26 June 2019
Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies	TA171	18 June 2009	26 June 2019
Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib	TA586	26 June 2019	26 June 2019
Lenalidomide plus dexamethasone for previously untreated multiple myeloma	TA587	26 June 2019	26 June 2019
Ocrelizumab for treating primary progressive multiple sclerosis	TA585	12 June 2019	12 June 2019
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes	TA583	5 June 2019	5 June 2019